About Systemic Lupus Erythematosus (SLE)

Overview

Systemic lupus erythematosus (SLE), also known as lupus, is a chronic autoimmune disease that affects various parts of the body. It occurs when the immune system mistakenly attacks healthy cells and tissues, leading to inflammation and potential damage to organs such as the skin, joints, heart, lungs, kidneys, and brain. SLE is characterized by the immune system producing harmful antibodies that attack healthy tissues, the body’s inability to clear these antibodies, and the buildup of harmful substances in tissues and organs that can cause inflammation and damage. This immune system dysfunction can result in multiple organ system damage. People with SLE may experience periods of illness (flares) and periods of wellness (remission). The severity and pattern of flares can vary among individuals. Although there is no cure for SLE, with appropriate treatment and management, many people with the condition can effectively control their symptoms and lead fulfilling lives.

Causes and Risk Factors

While the exact root causes are still not fully understood, several factors have been identified as contributing to the development of systemic lupus erythematosus (SLE):

• Genetic factors: Certain genes may increase the risk of developing SLE, although it is not solely determined by genetics.
• Hormonal factors: Hormonal imbalances, such as increased estrogen levels, are believed to play a role in SLE development.
• Environmental factors: Exposure to certain viral infections, sunlight, certain medications, and smoking may trigger or worsen SLE symptoms.

As for the risk factors of SLE, they can be categorized into non-modifiable and modifiable factors:

Non-modifiable risk factors for SLE cannot be changed or controlled. These include:

• Gender: Women are more likely to develop SLE than men.
• Age: SLE most commonly affects women of childbearing age.

Modifiable risk factors for SLE can be influenced or changed. These include:

• Smoking: Smoking has been associated with an increased risk of developing SLE.
• Medications: Certain medications, such as hydralazine and procainamide, have been linked to drug-induced lupus.

It's important to note that while these risk factors may increase the likelihood of developing SLE, they do not guarantee its occurrence. If you have concerns about your risk for SLE or want to learn more about managing the condition, consult with your healthcare professional.

Symptoms

The most common early symptoms of systemic lupus erythematosus (SLE) include:

• Fatigue
• Joint pain
• Skin rash, particularly on the face (butterfly rash)
• Fever

As SLE progresses or becomes more severe, additional symptoms may occur. Some of these symptoms include:

• Hair loss
• Sun sensitivity
• Swelling and pain in the joints
• Unexplained fever
• Kidney problems
• Oral lesions (such as mouth ulcers and dry mouth)
• Cognitive dysfunction (such as memory problems and difficulty concentrating)
• Headaches and seizures
• Psychosis: A condition where someone has trouble telling what’s real, often seeing or hearing things that aren’t there, or believing thing that aren’t true
• Increased risk of blood clots

It's important to note that SLE symptoms can vary from person to person, and not everyone will experience the same symptoms or in the same order. If you are experiencing any concerning symptoms, it is recommended to consult with a healthcare professional for an accurate diagnosis and appropriate management plan.

Diagnosis

To diagnose systemic lupus erythematosus (SLE), healthcare providers commonly perform the following examinations, tests, and procedures:

• Medical history and symptoms: Your healthcare provider will gather information about your medical history and ask about any symptoms you may be experiencing.
• Physical exam: During a physical exam, the healthcare professional looks for signs of SLE, such a joint pain or swelling, skin rashes, and signs of inflammation in different parts of the body.
• Laboratory tests: Blood and urine tests may be ordered to check for specific markers associated with SLE, such as acomplete blood count (CBC) to detect blood abnormalities, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) for inflammation, antinuclear antibody (ANA) for autoimmune activity, and anti-double-stranded DNA (anti-dsDNA) antibodies to assess SLE specific activity.
• Biopsy: In some cases, a biopsy of the skin or kidney may be performed. A small sample of tissue is taken and examined under a microscope to look for characteristic changes associated with SLE.

To assess the activity and extent of SLE involvement, additional examinations, tests, and procedures may include:

• Imaging studies: Your healthcare provider may recommend imaging studies such as X-rays or MRI (magnetic resonance imaging) scans to evaluate the involvement of specific organs or joints.
• Clinical procedures: Depending on your symptoms and suspected organ involvement, additional clinical procedures may be performed. These can include echocardiogram for heart evaluation, pulmonary function tests for lung function assessment, or kidney function tests.

It's important to note that the specific examinations, tests, and procedures may vary depending on individual cases. It's best to consult with your healthcare provider for personalized recommendations.

Treatment Options

The goals of treatment for systemic lupus erythematosus (SLE) are as follows:

• Manage symptoms: The primary goal is to alleviate symptoms such as joint pain, fatigue, and skin rashes.
• Prevent, limit, and stop flares: Treatment aims to minimize the frequency and severity of disease flares, which are periods of increased disease activity.
• Maintain the lowest level of disease activity: The objective is to keep the disease under control and minimize its impact on daily life.
• Prevent or slow organ damage: Treatment focuses on protecting organs from damage caused by inflammation.
• Improve quality of life: The overall aim is to enhance the patient's well-being and ability to function.

To achieve these goals, the following treatments may be recommended:

• Medications:
  • Anti-inflammatory drugs can help manage pain and fever associated with SLE.
  • Antimalarials have been found useful in treating fatigue, joint pain, skin rashes, and lung inflammation caused by SLE.
  • Corticosteroids are potent anti-inflammatory drugs that help reduce inflammation in the body.
• Therapies: Non-medication therapies such as exercise have shown promise in improving physical fitness, reducing symptoms, and enhancing overall quality of life for patients with SLE.
• Self-care and health behavior changes: Lifestyle modifications like stress management techniques, regular exercise, and a healthy diet can contribute to overall well-being and may help manage SLE symptoms.

It's important to note that treatment plans are individualized based on each patient's specific needs and may involve a combination of these approaches. Consult with your healthcare professional for personalized advice.

Medication dosing may be affected by many factors. Check with your healthcare professional about dosing for your individual situation. Side effects can occur. Check with your healthcare professional or read the information provided with your medication for side effect information.